| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 27 |
| 1 | ALBUTEROL SULFATE | 24 |
| 2 | MONTELUKAST SODIUM | 24 |
| 3 | TIOTROPIUM BROMIDE | 24 |
| 4 | MOMETASONE FUROATE | 22 |
| 5 | PANTOPRAZOLE | 22 |
| 6 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 21 |
| 7 | THEOPHYLLINE ANHYDROUS | 21 |
| 8 | ACLIDINIUM BROMIDE | 20 |
| 9 | ESOMEPRAZOLE MAGNESIUM | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MINOXIDIL 2% | 1 | 0.0370 |
| 1 | ACLIDINIUM BROMIDE | 20 | 0.0031 |
| 2 | THEOPHYLLINE ANHYDROUS | 21 | 0.0017 |
| 3 | ZILEUTON | 1 | 0.0015 |
| 4 | MERCAPTOPURINE | 19 | 0.0011 |
| 5 | TIOTROPIUM BROMIDE INHALATION SPRAY | 8 | 0.0007 |
| 6 | MOMETASONE FUROATE | 22 | 0.0005 |
| 7 | CANDESARTAN | 17 | 0.0005 |
| 8 | ESOMEPRAZOLE MAGNESIUM DIHYDRATE | 5 | 0.0003 |
| 9 | DESOGESTREL AND ETHINYL ESTRADIOL | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 33 |
| 1 | Methylxanthine [EPC] | 21 |
| 2 | Proton Pump Inhibitor [EPC] | 19 |
| 3 | Histamine-1 Receptor Antagonist [EPC] | 5 |
| 4 | Anti-IgE [EPC] | 3 |
| 5 | Arteriolar Vasodilator [EPC] | 3 |
| 6 | Macrolide Antimicrobial [EPC] | 3 |
| 7 | 5-alpha Reductase Inhibitor [EPC] | 2 |
| 8 | Insulin Analog [EPC] | 2 |
| 9 | Interleukin-17A Antagonist [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | 5-Lipoxygenase Inhibitor [EPC] | 1 | 0.0015 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Methylxanthine [EPC] | 21 | 0.0004 |
| 3 | Leukotriene Receptor Antagonist [EPC] | 2 | 0.0001 |
| 4 | Histamine-1 Receptor Antagonist [EPC] | 5 | 0.0001 |
| 5 | Macrolide Antimicrobial [EPC] | 3 | 0.0001 |
| 6 | Interleukin-17A Antagonist [EPC] | 2 | 0.0001 |
| 7 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 8 | Aluminum Complex [EPC] | 1 | 0.0000 |
| 9 | Arteriolar Vasodilator [EPC] | 3 | 0.0000 |